Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,864 public trials 1,418 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Completed

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

NCT01120249

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Gulf Coast MBCCOP Mobile, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1003 locations
View Trial Details
Completed

Vascular Thrombus Involvement in Nephroblastoma

NCT05195411

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Hôpital Kremlin Bicêtre Le Kremlin-Bicêtre, France
  • Hôpital Necker-Enfants Malades Paris, France
View Trial Details
Completed

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

NCT06264752

Conditions
Acute Kidney Injury, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +7 more
Locations
  • UPMC Altoona Altoona, Pennsylvania, United States
  • UPMC Horizon Farrell, Pennsylvania, United States
  • UPMC McKeesport McKeesport, Pennsylvania, United States
  • UPMC Jameson New Castle, Pennsylvania, United States
View Trial Details
Completed

A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)

NCT05656040

Conditions
Chronic Disease, Disease Attributes, End-stage Kidney Disease, +12 more
Locations
  • Velocity Clinical Research, New Smyrna Beach ( Site 0003) Edgewater, Florida, United States
  • Advanced Pharma CR, LLC ( Site 0006) Miami, Florida, United States
  • Genesis Clinical Research, LLC ( Site 0004) Tampa, Florida, United States
  • Alliance for Multispecialty Research, LLC ( Site 0002) Knoxville, Tennessee, United States
View Trial Details
Completed

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

NCT03763643

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • University of Alabama Tuscaloosa, Alabama, United States
  • University of California at Davis Davis, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

NCT05836220

Conditions
Chronic Disease, Disease Attributes, End Stage Kidney Disease, +16 more
Locations
  • Site Number: USA039-2 Anaheim, California, United States
  • Site Number: USA001-2 Chula Vista, California, United States
  • Site Number: USA020-2 Escondido, California, United States
  • Site Number: USA042-2 Fresno, California, United States
View all 68 locations
View Trial Details
Completed

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1

NCT05832931

Conditions
Chronic Disease, Disease Attributes, End-Stage Kidney Disease (ESKD), +16 more
Locations
  • Site Number: USA016-1 Pine Bluff, Arkansas, United States
  • Site Number: USA032-1 Anaheim, California, United States
  • Site Number: USA031-1 Beverly Hills, California, United States
  • Site Number: USA020-1 Fairfield, California, United States
View all 68 locations
View Trial Details
Completed

Adipose Tissue & Uremia

NCT02902705

Conditions
Chronic Disease, Chronic Kidney Disease - Stage V, Disease Attributes, +11 more
Locations
  • Service de Néphrologie, dialyse, hypertension artérielle - Pavillon P - Hôpital Edouard Herriot - Lyon, France
View Trial Details

Related conditions